SSRIs double the risk of suicide and violence in healthy adultsBMJ 2016; 355 doi: https://doi.org/10.1136/bmj.i5504 (Published 12 October 2016) Cite this as: BMJ 2016;355:i5504
- Ingrid Torjesen
Selective serotonin and serotonin-norepinephrine (noradrenaline) reuptake inhibitors double the risk of suicide and violence in healthy adults with no signs of a mental disorder, a systematic review has found.
The review, published in the Journal of the Royal Society of Medicine, is the first to analyse trials of these antidepressants in healthy adults.1 Researchers from the Nordic Cochrane Centre and University of Copenhagen in Denmark identified 130 double blind, randomised placebo controlled trials through PubMed and Embase and 29 …
Log in using your username and password
Log in through your institution
Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
Sign up for a free trial